Tiny 'Magic Mushroom' doses tested for emotional relief

NCT ID NCT05227742

Summary

This early-stage study aimed to test whether very small, non-hallucinogenic doses of psilocybin (a compound from 'magic mushrooms') could help reduce feelings of hopelessness and meaninglessness in adults. The study planned to give participants weekly doses for five weeks while measuring their emotional state and brain activity. The trial was withdrawn by the researchers before any participants were enrolled.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMORALIZATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35209, United States

Conditions

Explore the condition pages connected to this study.